Brainsway Ltd Asset Resilience Ratio
Brainsway Ltd asset resilience ratio. Brainsway Ltd (BWAY) has an Asset Resilience Ratio of 0.87% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See BWAY cash and liquid assets coverage to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Brainsway Ltd (2012–2025)
Asset resilience ratio of Brainsway Ltd from 2012 to 2025. This chart shows how Brainsway Ltd's Asset Resilience Ratio has changed over time. Read BWAY current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Brainsway Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see Brainsway Ltd (BWAY) total assets.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $1.06 Million | 0.87% |
| Total Liquid Assets | $1.06 Million | 0.87% |
Asset Resilience Insights
- Limited Liquidity: Brainsway Ltd maintains only 0.87% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
Brainsway Ltd Industry Peers by Asset Resilience Ratio
Compare Brainsway Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832 |
Medical Devices | 9.95% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 12.59% |
|
BMC Medical Co. Ltd. A
SHE:301367 |
Medical Devices | 44.96% |
|
Emvision Medical Devices Ltd
AU:EMV |
Medical Devices | 0.06% |
|
Hironic Co. Ltd
KQ:149980 |
Medical Devices | 17.42% |
|
DRGEM Corporation
KQ:263690 |
Medical Devices | 2.12% |
|
Oncosil Medical Ltd
AU:OSL |
Medical Devices | 0.00% |
|
Adherium Ltd
AU:ADR |
Medical Devices | 15.45% |
Brainsway Ltd Asset Resilience Ratio by Year (2012–2025)
Brainsway Ltd asset resilience ratio by year from 2012 to 2025. The table below shows the annual Asset Resilience Ratio data for Brainsway Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 1.27% | $1.43 Million | $112.92 Million | -- |
| 2024-12-31 | 0.00% | $0.00 | $94.32 Million | -- |
| 2023-12-31 | 56.32% | $35.47 Million | $62.97 Million | +55.90pp |
| 2022-12-31 | 0.42% | $271.00K | $64.48 Million | -52.96pp |
| 2021-12-31 | 53.38% | $40.43 Million | $75.73 Million | +52.73pp |
| 2020-12-31 | 0.65% | $221.00K | $34.01 Million | +0.08pp |
| 2019-12-31 | 0.57% | $221.00K | $38.74 Million | +0.14pp |
| 2018-12-31 | 0.43% | $101.00K | $23.60 Million | +0.24pp |
| 2017-12-31 | 0.18% | $50.00K | $27.03 Million | -2.75pp |
| 2016-12-31 | 2.93% | $585.00K | $19.96 Million | +0.30pp |
| 2015-12-31 | 2.63% | $585.00K | $22.24 Million | -1.56pp |
| 2014-12-31 | 4.19% | $1.08 Million | $25.77 Million | -3.98pp |
| 2013-12-31 | 8.16% | $1.46 Million | $17.85 Million | -1.74pp |
| 2012-12-31 | 9.91% | $1.06 Million | $10.70 Million | -- |
About Brainsway Ltd
BrainsWay Ltd. develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States and internationally. It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious and late-life depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post-traumatic stress disorders, … Read more